Eve & Co Incorporated (EEVVF) Stock Price & Growth Analysis

Quote Panel

Updated October 19, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
2.86M
Shares Outstanding
36.75M
Share in Float
Dividende
0

Earning Date
No Data
Price Target
0.0777
Average Volume
Beta
0.601455

Range
0.074-0.122
Industry
Drug Manufacturers - Specialty & Generic
Website
https://www.evecannabis.ca
Sector
Healthcare

Quote Panel

Updated October 19, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

N/A

P/E Ratio

1066.10x

P/S Ratio

0.12x

P/B Ratio

0.0

Debt/Equity

-287.9%

Net Margin

$-0.1

EPS

How EEVVF compares to sector?

P/E Ratio

Fundamentals

Relative Strength

EEVVF

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

EEVVF

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

N/A

2025-Revenue

N/A

2025-EPS

N/A

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Price Target

N/A(N/A)

Number of analyst

N/A

Last analyst upgrade/downgrade

No Data Available

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q2.19

+132%

0.01
vs -0.03

Q3.19

N/A

-0.05
vs -0.16

Q4.19

N/A

-0.08
vs -0.12

Q1.20

N/A

-0.04
vs -0.03

Q2.20

-95%

0
vs 0.01

Q3.20

N/A

-0.11
vs -0.05

Q4.20

N/A

-0.10
vs -0.08

Q1.21

N/A

-0.06
vs -0.04

Q2.21

+1325%

0.01
vs 0

Q3.21

N/A

-0.01
vs -0.11

Sales Growth

YoY

Current

Estimates

Q2.19

331.8622249 vs NA

Q3.19

-51%

650.5778013 vs 1.3K

Q4.19

-74%

426.410677 vs 1.6K

Q1.20

-79%

266.6285284 vs 1.3K

Q2.20

+183%

939.6079789 vs 331.8622249

Q3.20

-27%

476.1457418 vs 650.5778013

Q4.20

+107%

883.0582669 vs 426.410677

Q1.21

+513%

1.6K vs 266.6285284

Q2.21

-3%

911.1401492 vs 939.6079789

Q3.21

+240%

1.6K vs 476.1457418

Return on Equity

QoQ

Q2.19

+1%

0.01
vs -0.05

Q3.19

-6%

-0.06
vs 0.01

Q4.19

-10%

-0.10
vs -0.06

Q1.20

-6%

-0.06
vs -0.10

Q2.20

+0%

0
vs -0.06

Q3.20

-16%

-0.16
vs 0

Q4.20

-17%

-0.17
vs -0.16

Q1.21

-10%

-0.10
vs -0.17

Q2.21

+1%

0.01
vs -0.10

Q3.21

-1%

-0.01
vs 0.01

Institutionnal Ownership

N/A

Q3.23

NA
vs NA

Q4.23

NA
vs NA

Q1.24

NA
vs NA

Q2.24

NA
vs NA

Q3.24

NA
vs NA

Q4.24

NA
vs NA

Q1.25

NA
vs NA

Q2.25

NA
vs NA

Q3.25

NA
vs NA

Q4.25

NA
vs NA

Earnings Growth

YoY

Current

Estimates

Q2.19

+132%

0.01
vs -0.03

Q3.19

N/A

-0.05
vs -0.16

Q4.19

N/A

-0.08
vs -0.12

Q1.20

N/A

-0.04
vs -0.03

Q2.20

-95%

0
vs 0.01

Q3.20

N/A

-0.11
vs -0.05

Q4.20

N/A

-0.10
vs -0.08

Q1.21

N/A

-0.06
vs -0.04

Q2.21

+1325%

0.01
vs 0

Q3.21

N/A

-0.01
vs -0.11

Sales Growth

YoY

Current

Estimates

Q2.19

331.8622249 vs NA

Q3.19

-51%

650.5778013 vs 1.3K

Q4.19

-74%

426.410677 vs 1.6K

Q1.20

-79%

266.6285284 vs 1.3K

Q2.20

+183%

939.6079789 vs 331.8622249

Q3.20

-27%

476.1457418 vs 650.5778013

Q4.20

+107%

883.0582669 vs 426.410677

Q1.21

+513%

1.6K vs 266.6285284

Q2.21

-3%

911.1401492 vs 939.6079789

Q3.21

+240%

1.6K vs 476.1457418

Return on Equity

QoQ

Q2.19

+1%

0.01
vs -0.05

Q3.19

-6%

-0.06
vs 0.01

Q4.19

-10%

-0.10
vs -0.06

Q1.20

-6%

-0.06
vs -0.10

Q2.20

+0%

0
vs -0.06

Q3.20

-16%

-0.16
vs 0

Q4.20

-17%

-0.17
vs -0.16

Q1.21

-10%

-0.10
vs -0.17

Q2.21

+1%

0.01
vs -0.10

Q3.21

-1%

-0.01
vs 0.01

Institutionnal Ownership

N/A

Q3.23

NA
vs NA

Q4.23

NA
vs NA

Q1.24

NA
vs NA

Q2.24

NA
vs NA

Q3.24

NA
vs NA

Q4.24

NA
vs NA

Q1.25

NA
vs NA

Q2.25

NA
vs NA

Q3.25

NA
vs NA

Q4.25

NA
vs NA

Company Description

0.08USD

N/A

1066.10x

0.12x

0.0

-287.9%

$-0.1

N/A

N/A

N/A

Earnings Growth

Latest News

Latest News

Latest News

Earnings Growth

Company Description

0.08USD

N/A

N/A

N/A

N/A

1066.10x

0.12x

0.0

-287.9%

$-0.1